Analysis of stage III stomach cancer using the restricted mean survival time

被引:0
|
作者
Kim, Bitna [1 ]
Lee, Minjung [1 ]
机构
[1] Kangwon Natl Univ, Dept Stat, 1 Kangwondaehak Gil, Chuncheon Si 24341, Gangwon Do, South Korea
基金
新加坡国家研究基金会;
关键词
pseudo-observations; restricted mean survival time; stomach cancer; survival analysis; LONGITUDINAL DATA-ANALYSIS; DIFFERENCE; TESTS;
D O I
10.5351/KJAS.2021.34.2.255
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
The purpose of this study is to compare the effects of treatment on stage III stomach cancer data obtained from the SEER program of the National Cancer Institute and to identify the significant risk factors for the survival rates of stage III stomach cancer. Since the proportional hazards assumption was violated for treatment, we used the restricted mean survival time as an alternative to the proportional hazards model. The restricted mean survival time was estimated using pseudo-observations, and the effects of treatment were compared using a test statistic based on the estimated restricted mean survival times. We conducted the regression analysis using a generalized linear model to investigate the significant predictors for the restricted mean survival time of patients with stage III stomach cancer. We found that there was a significant difference between the restricted mean survival times of treatment groups. Age at diagnosis, race, substage, grade, tumor size, surgery, and treatment were significant predictors for the restricted mean survival time of patients with stage III stomach cancer. Surgery was the most significant predictor for increasing the restricted mean survival time of patients with stage III stomach cancer.
引用
收藏
页码:255 / 266
页数:12
相关论文
共 50 条
  • [1] On the Restricted Mean Survival Time Curve in Survival Analysis
    Zhao, Lihui
    Claggett, Brian
    Tian, Lu
    Uno, Hajime
    Pfeffer, Marc A.
    Solomon, Scott D.
    Trippa, Lorenzo
    Wei, L. J.
    [J]. BIOMETRICS, 2016, 72 (01) : 215 - 221
  • [3] Bayesian nonparametric analysis of restricted mean survival time
    Zhang, Chenyang
    Yin, Guosheng
    [J]. BIOMETRICS, 2023, 79 (02) : 1383 - 1396
  • [4] Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time
    Messori, Andrea
    Bartoli, Laura
    Trippoli, Sabrina
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1208 - 1209
  • [5] Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis
    Charu, Vivek
    Tian, Lu
    Tamura, Manjula Kurella
    Montez-Rath, Maria E.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (02): : 260 - 262
  • [6] Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?
    A'Hern, Roger P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3474 - +
  • [7] Restricted Mean Survival Time for Survival Analysis: A Quick Guide for Clinical Researchers
    Han, Kyunghwa
    Jung, Inkyung
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2022, 23 (05) : 495 - 499
  • [8] Assessing surrogacy using restricted mean survival time ratio for overall survival in liver cancer: a narrative review
    Leung, Tiffany H.
    Ho, James C.
    Wang, Xiaofei
    Pang, Herbert
    [J]. CHINESE CLINICAL ONCOLOGY, 2023, 12 (05)
  • [9] Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards
    Yang, Zijing
    Wu, Hongji
    Hou, Yawen
    Yuan, Hao
    Chen, Zheng
    [J]. Computer Methods and Programs in Biomedicine, 2021, 207
  • [10] Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards
    Yang, Zijing
    Wu, Hongji
    Hou, Yawen
    Yuan, Hao
    Chen, Zheng
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 207